Woodie M. Zachry, Ph.D.
Affiliations: | 2000 | University of Texas at Austin, Austin, Texas, U.S.A. |
Area:
Pharmacy, Marketing Business AdministrationGoogle:
"Woodie Zachry"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Marvin D. Shepherd | grad student | 2000 | UT Austin | |
| (A study of the relationship of direct -to -consumer advertising to epidemiologic indices.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zachry W, Halajko D, Hayes V, et al. (2018) Cost Benefit and Break-Even Analysis of Screening for Non-Alcoholic Fatty Liver Disease Utilizing FibroScan as Compared to Usual Care: 1011 The American Journal of Gastroenterology. 113 |
| Lang K, Korn JR, Simko RJ, et al. (2010) Development of an interactive model of the burden of future coronary heart disease from an employer perspective. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 52: 851-7 |
| Zachry WM, Doan QD, Smith BJ, et al. (2009) Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting. Epilepsy & Behavior : E&B. 16: 268-73 |
| Brown CM, Nwokeji E, Rascati KL, et al. (2009) Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers. Administration and Policy in Mental Health. 36: 278-87 |
| Zachry WM, Doan QD, Clewell JD, et al. (2009) Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes. Epilepsia. 50: 493-500 |
| Brown CM, Richards K, Rascati KL, et al. (2008) Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers' perspective. Administration and Policy in Mental Health. 35: 181-8 |
| Abarca J, Malone DC, Armstrong EP, et al. (2004) Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization. Pharmacotherapy. 24: 351-7 |
| Zachry WM, Dalen JE, Jackson TR. (2003) Clinicians' responses to direct-to-consumer advertising of prescription medications. Archives of Internal Medicine. 163: 1808-12 |
| Vogel RJ, Ramachandran S, Zachry WM. (2003) A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals. Clinical Therapeutics. 25: 309-29 |
| Zachry WM. (2003) Analysis of the Relationship of Direct-to-Consumer Advertising and Patients Seeking Ambulatory Care Journal of Pharmaceutical Marketing & Management. 15: 45-59 |